MedTrace Logo

Assessing the Efficacy and Safety of Photobiomodulation for the Treatment of Pruritus

NCT07450716 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-04-13

No results posted yet for this study

Summary

This study is designed to evaluate the safety and effectiveness of a low-level near-infrared LED light device for relieving itch. The device is non-invasive, does not break the skin, and does not produce heat. Near-infrared light has been used in other medical settings and is known to interact with skin and nerve pathways. In this study, researchers are examining whether this light can be safely applied to the skin and whether it may help reduce itch by affecting signals involved in itch sensation.

Conditions

Interventions

DEVICE

Light-emitting diode (LED) Photobiomodulation (PBM) device

Near-infrared light treatment will be administered to an area on the body experiencing itch.

OTHER

Placebo

Matching placebo delivered by placing the device above the skin on an area contralateral to the treatment area without activating it.

Sponsors & Collaborators

Principal Investigators

  • Richard R. Anderson, MD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2026-12-31
Completion
2026-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07450716 on ClinicalTrials.gov